Bank Of America Corp Talaris Therapeutics, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.78 - $3.2 $16,732 - $30,080	-9,400 Reduced 35.66%	16,957 $51,000
Q1 2023 May 12, 2023	BUY	$1.09 - $2.09 $6,436 - $12,341	5,905 Added 28.87%	26,357 $49,000
Q4 2022 Feb 10, 2023	BUY	$0.94 - $1.64 $2,322 - $4,052	2,471 Added 13.74%	20,452 $20,000
Q3 2022 Nov 14, 2022	BUY	$2.3 - $5.03 $14,471 - $31,648	6,292 Added 53.83%	17,981 $47,000
Q2 2022 Aug 12, 2022	BUY	$4.51 - $9.85 $2,480 - $5,417	550 Added 4.94%	11,689 $52,000
Q1 2022 May 16, 2022	SELL	$6.89 - $16.56 $111,376 - $267,692	-16,165 Reduced 59.2%	11,139 $110,000
Q4 2021 Feb 08, 2022	BUY	$12.18 - $17.0 $78,646 - $109,769	6,457 Added 30.97%	27,304 $417,000
Q3 2021 Nov 15, 2021	BUY	$11.61 - $15.99 $194,966 - $268,520	16,793 Added 414.23%	20,847 $283,000
Q2 2021 Sep 13, 2021	BUY	$12.25 - $18.61 $49,661 - $75,444	4,054 New	4,054 $59,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.